Engineered Prenyltransferases for Higher-Yield Cannabinoid Biosynthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing cannabinoids, such as Δ9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD), face challenges including high production costs, low yields, and environmental impact due to chemical synthesis, while agricultural extraction is susceptible to climate and disease.
Innovation Solution
Employing recombinant polypeptides with amino acid sequences similar to prenyltransferases, modified to enhance the production of prenylated products like cannabinoids by converting substrates and prenyl donors, achieving higher yields and cost-effectiveness.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If chemical synthesis is used to produce cannabinoids, then production cost and yield are improved, but environmental impact and complexity increase
Solution Approach 1:
The patent replaces chemical synthesis methods with biological enzymatic systems. Recombinant prenymethyltransferase enzymes catalyze the prenylation of aromatic substrates to produce cannabinoids, substituting complex chemical reaction sequences with a single biological catalytic step. This reduces environmental impact while maintaining productivity.
Solution Approach 2:
The patent modifies enzyme parameters through amino acid substitutions in the prenymethyltransferase sequence to optimize catalytic activity and substrate specificity. These parameter changes enable the enzyme to efficiently produce desired cannabinoid products while avoiding harmful byproducts associated with chemical synthesis.
2Object-affected harmful factors
If agricultural production is used to extract cannabinoids, then environmental friendliness is improved, but susceptibility to climate and disease reduces reliability
Solution Approach 1:
The patent uses recombinant enzymes as intermediaries to transfer the desirable properties of plant-based cannabinoid production (environmental friendliness) while eliminating the disadvantages (climate and disease susceptibility). The enzymes are produced in controlled microbial or cell culture systems, serving as a bridge between agricultural and industrial approaches.
Solution Approach 2:
The patent creates copies of the prenymethyltransferase enzyme gene and expresses them in controlled environments such as microbial hosts or cell cultures. This copying approach allows production to occur in standardized, controlled settings that are not susceptible to climate or plant diseases, while maintaining the environmental benefits of biological production.
3Ease of manufacture
If plant extraction is used to obtain cannabinoids, then production method simplicity is improved, but low content of less-abundant cannabinoids reduces productivity
Solution Approach 1:
The patent engineering prenymethyltransferase enzymes with broad substrate specificity to accept multiple aromatic substrates (e.g., olivetolic acid, divarinolic acid, orsellinic acid). This enables a single enzyme system to produce multiple different cannabinoids including less-abundant varieties, making the process universally applicable to diverse cannabinoid production while maintaining simplicity.
4Adaptability or versatility
If complex chemical synthesis is used to produce diverse cannabinoids, then product diversity is improved, but production cost and complexity increase
Solution Approach 1:
The patent designs prenymethyltransferase enzymes with broad substrate acceptance capabilities, allowing a single enzyme to catalyze the formation of multiple different cannabinoid structures from various aromatic precursors. This multi-functionality enables diverse cannabinoid production through a unified, simple enzymatic pathway rather than multiple complex chemical synthesis routes.
Solution Approach 2:
The patent employs amino acid substitutions in the prenymethyltransferase sequence to tune enzyme properties for accepting diverse substrates and producing varied cannabinoid products. These parameter modifications enable the enzyme to function across multiple product types while maintaining a single, simple catalytic mechanism.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The modified recombinant polypeptides increase the ratio of prenylated products, offering a biotechnology-based, cost-effective, and environmentally friendly method for synthesizing diverse cannabinoids.
Implementation Method 1
the recombinant polypeptide converts a substrate and a prenymethyl donor to at least one prenymethylated product
Data Source
AI summary
The disclosure relates to the biosynthesis of cannabinoids and related prenylated phenolic compounds using recombinant enzymes. In particular, the disclosure provides recombinant prenyltransferase enzymes engineered to produce a greater amount of a desired product, or to have a greater ability to catalyze a reaction using a desired substrate, as compared to the wild type prenyltransferase. The disclosure also provides methods of preparing such recombinant enzymes; as well as methods of use thereof in improving the biosynthesis of cannabinoids and related prenylated phenolic compounds.